I en undersøgelse hos individer med varierende grad af nyresinsufficiens, havde mild til moderat nyresygdom ingen indflydelse på rosuvastatin’ s eller N- desmethyl metabolittens plasmakoncentration.
In a study in subjects with varying degrees of renal impairment, mild to moderate renal disease had no influence on plasma concentration of rosuvastatin or the N-desmethyl metabolite.